Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical riluzole plaque test in stable plaque psoriasis
2007-007037-39Phase 2Completed
- Sponsor
- Biofrontera
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of riluzole in plaque psoriasis (3 arms), sponsored by Biofrontera. Primary endpoint: Clinical score of psoriatic lesions. Started Dec 2007; status: completed.
02
Drugs
riluzole
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2007-007037-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007037-39.